(Figure 3A) MDMs from lung cancer patients (CA-MDM), being derived from S100A9-enriched monocytes, retained higher expression of S100A9 and expressed stronger CD206, a marker for M2 macrophages. This evidence concerns the gene S100A9 and lung cancer.